Kailera Therapeutics to Participate in September Investor Conferences
Kailera Therapeutics, a clinical-stage biotech focused on innovative obesity treatments, will participate in prominent September 2026 investor conferences including Bernstein Insights and Stifel's Cardiometabolic Forum. The company will feature discussions with its leadership on pipeline progress and strategic vision. Kailera is advancing four clin…